Search Within

Marina K Baine

Formats
  1. Meeting Abstract (33)
  2. Journal Article (21)
  3. Review (2)
  4. Correspondence (1)
  5. Editorial (1)
Groups
  1. Department of Pathology and Laboratory Medicine (58)
  2. Department of Medicine (39)
  3. Solid Tumor Oncology Division (36)
  4. GSK Faculty (32)
  5. Thoracic Oncology (32)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (25)

More Groups

People
  1. Natasha Rekhtman (46)
  2. William Travis (29)
  3. Charles Rudin (25)
  4. Jason Chang (22)
  5. Jennifer Sauter (22)
  6. Jacklynn Egger (18)

More People

Years
  1. 2025 (11)
  2. 2024 (6)
  3. 2023 (8)
  4. 2022 (10)
  5. 2021 (14)
  6. 2020 (9)
Publications
  1. Laboratory Investigation (23)
  2. Modern Pathology (10)
  3. Cancer Cell (2)
  4. Cancer Discovery (2)
  5. Clinical Cancer Research (2)
  6. Journal of Thoracic Oncology (2)

More Publications

Publishers
  1. Nature Publishing Group (25)
  2. Nature Research (10)
  3. American Association for Cancer Research (4)
  4. Oxford University Press (4)
  5. American Society of Clinical Oncology (2)
  6. Cell Press (2)

More Publishers

Results (58)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Analysis of ASCL1/NEUROD1/POU2F3/YAP1 yields novel insights for the diagnosis of olfactory neuroblastoma and identifies sinonasal tuft cell–like carcinoma
    Journal Article

    Febres-Aldana, C. A.; Elsayad, M. M.; Saliba, M.; Bhanot, U.; Ntiamoah, P.; Takeyama, A.; Purgina, B. M.; Rodriguez-Urrego, P. A.; Marusic, Z.; Jakovcevic, A.; more...
    Modern Pathology (2025)

    Fulltext@MSK | Save
  • First report of response to tarlatamab in a patient with DLL3-positive pulmonary carcinoid: Case report
    Journal Article

    Cooper, A. J.; Rekhtman, N.; Baine, M. K.; Thomas, M. C.; Lynch, A. C.; Gentzler, R. D.
    JTO Clinical and Research Reports (2024)

    Fulltext@MSK | Save
  • Lung neuroendocrine neoplasms harboring ALK, RET and other receptor tyrosine kinase fusions: Spectrum of pathologic features from conventional neuroendocrine carcinomas to unusual carcinoid-type tumors with focal mucin or adenocarcinoma components
    Meeting Abstract

    Armstrong, S.; Chang, J.; Yang, S. R.; Samuel, T.; Hussain, S.; Velez, M.; Baine, M.; Travis, W.; Drilon, A.; Quintanal-Villalonga, A.; more...
    Laboratory Investigation (2024)

    Fulltext@MSK | Save
  • A phase I/II study of valemetostat (DS-3201b), an EZH1/2 inhibitor, in combination with irinotecan in patients with recurrent small-cell lung cancer
    Journal Article

    Choudhury, N. J.; Lai, W. V.; Makhnin, A.; Heller, G.; Eng, J.; Li, B.; Preeshagul, I.; Santini, F. C.; Offin, M.; Ng, K.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Differential NEUROD1, ASCL1, and POU2F3 expression defines molecular subsets of bladder small cell/neuroendocrine carcinoma with prognostic implications
    Journal Article

    Akbulut, D.; Whiting, K.; Teo, M. Y.; Tallman, J. E.; Ozcan, G. G.; Basar, M.; Jia, L.; Rammal, R.; Chen, J. F.; Sarungbam, J.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • Prognostic implications of small cell lung cancer transcriptional subtyping for CNS metastases
    Journal Article

    Tringale, K. R.; Skakodub, A.; Egger, J.; Eichholz, J.; Yu, Y.; Gomez, D.; Rimner, A.; Li, B.; Yamada, Y.; Wilcox, J.; more...
    JCO Precision Oncology (2024)

    Fulltext@MSK | Save
  • Imaging with [(89)Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with high-grade neuroendocrine tumours of the lung and prostate: A phase 1/2, first-in-human trial
    Journal Article

    Tendler, S.; Dunphy, M. P.; Agee, M.; O'Donoghue, J.; Aly, R. G.; Choudhury, N. J.; Kesner, A.; Kirov, A.; Mauguen, A.; Baine, M. K.; more...
    Lancet Oncology (2024)

    Fulltext@MSK | Save
  • Prognostic implications of small cell lung cancer (SCLC) transcriptional subtyping for central nervous system (CNS) metastases
    Meeting Abstract

    Skakodub, A.; Tringale, K.; Egger, J.; Eichholz, J.; Yu, Y.; Gomez, D.; Rimner, A.; Li, B.; Yamada, Y.; Wilcox, J.; more...
    Neuro-Oncology (2023)

    Fulltext@MSK | Save
  • Outcomes of combination platinum-doublet chemotherapy and anti-PD(L)-1 blockade in KRAS(G12C) mutant non-small cell lung cancer
    Journal Article

    Elkrief, A.; Riccuiti, B.; Alessi, J. V.; Fei, T.; Kalvin, H. L.; Egger, J. V.; Rizvi, H.; Thummalapalli, R.; Lamberti, G.; Plodkowski, A.; more...
    The Oncologist (2023)

    Fulltext@MSK | Save
  • Reliability of assessing morphologic features with prognostic significance in cytology specimens of epithelioid diffuse pleural mesothelioma and implications for cytopathology reporting
    Journal Article

    Li, Y.; Salama, A. M.; Baine, M. K.; Bodd, F. M.; Offin, M. D.; Rekhtman, N.; Zauderer, M. G.; Travis, W. D.; Adusumilli, P. S.; Sauter, J. L.
    Cancer Cytopathology (2023)

    Fulltext@MSK | Save